Last reviewed · How we verify

NCT03443011

Diagnostics in Diverticulitis (DIDit)

Completed NA Last updated 3 May 2018
What this trial tests

NA trial testing Low dose CT without intravenous contrast in Diverticulitis in 149 participants. Completed in 1 March 2018.

Timeline
19 January 2017
Primary endpoint
1 January 2018
1 March 2018

Quick facts

Lead sponsorUppsala University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment149
Start date19 January 2017
Primary completion1 January 2018
Estimated completion1 March 2018
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Uppsala University

Who can join

50 and older, any sex, with Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study focuses on if low dose CT without intravenous contrast has a high enough specificity and sensitivity for acute diverticulitis that it can be used as the primary diagnostic method instead of a full dose CT with intravenous contrast which is the standard method in Sweden.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diverticulitis

Currently open trials in the same condition.

Other Uppsala University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing